Canary Capital Amends Its Staked Injective ETF with US SEC, Will INJ Price Rally?

Canary Capital amended its staked Injective ETF filing with the U.S. Securities and Exchange Commission (SEC). The issuer has revealed significant changes to its prospectus to provide investors with regulated exposure to Injective and staking rewards. INJ price rebounded 5% to hit $8.6 in the last 24 hours. Ad Ad Canary Capital Updates Staked Injective